Lymphoseek® Performance vs. Sulfur Colloid in Breast Cancer Patients Published in Annals of Surgical Oncology; Fewer Nodal Dissections Required

Jan 29, 2015

Navidea’s Macrophage Therapeutics Unit Announces Plan for $2.5 Million Financing

Jan 21, 2015

Navidea Biopharmaceuticals to Present at Biotech Showcase 2015

Jan 6, 2015

Navidea Strengthens Leadership Team to Accelerate Lymphoseek® Growth

Jan 5, 2015

Data Presented by Independent Academic Collaborators Demonstrate Ability of Novel Manocept™ Immunotherapy to Kill Activated Macrophages from KS Patients

Dec 15, 2014

Macrophage Therapeutics to Present Data Supporting Potential for Breakthrough with Manocept™ in Immunotherapy

Dec 12, 2014

Navidea Forms Macrophage Therapeutics Business Unit to Explore Therapeutic Applications of Manocept™

Dec 10, 2014

Navidea Biopharmaceuticals to Present at the 2014 LD Micro Conference

Nov 25, 2014

European Commission Approves Navidea’s Sentinel Lymph Node Detection Agent Lymphoseek®

Nov 20, 2014

Navidea Receives $1.1Million PDUFA Filing Fee Refund for Award of Orphan Drug Status; Platinum Partners Reaffirms Commitment to Line of Credit

Nov 11, 2014